Evidence map›Paper›PMID 28627713›Full record

ArticleBiotechnology and bioengineering2017

Process development of human multipotent stromal cell microcarrier culture using an automated high-throughput microbioreactor.

Qasim A Rafiq, Mariana P Hanga, Thomas R J Heathman, Karen Coopman, Alvin W Nienow, David J Williams, Christopher J Hewitt

Abstract read
In one paragraph

Article in Biotechnology and bioengineering, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Review
  3. Edible Scaffolds for Cultivated Meat Production.Advances in biochemical engineering/biotechnology · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Needle to needle robot-assisted manufacture of cell therapy products.Bioengineering & translational medicine · 2022
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Expansion of human mesenchymal stem/stromal cells on temporary liquid microcarriers.Journal of chemical technology and biotechnology (Oxford, Oxfordshire : 1986) · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qasim A RafiqDepartment of Biochemical Engineering, Advanced Centre for Biochemical Engineering, University College London, Gower Street, London, United Kingdom.ORCID 0000-0003-4400-9106
Mariana P HangaAston Medical Research Institute, School of Life and Health Sciences, Aston University, Aston Triangle, Birmingham B4 7ET, United Kingdom.
Thomas R J HeathmanCentre for Biological Engineering, Loughborough University, Leicestershire LE11 3TU, United Kingdom.
Karen CoopmanCentre for Biological Engineering, Loughborough University, Leicestershire LE11 3TU, United Kingdom.
Alvin W NienowAston Medical Research Institute, School of Life and Health Sciences, Aston University, Aston Triangle, Birmingham B4 7ET, United Kingdom.
David J WilliamsCentre for Biological Engineering, Loughborough University, Leicestershire LE11 3TU, United Kingdom.
Christopher J HewittAston Medical Research Institute, School of Life and Health Sciences, Aston University, Aston Triangle, Birmingham B4 7ET, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbioreactors play a critical role in process development as they reduce reagent requirements and can facilitate high-throughput screening of process parameters and culture conditions. Here, we have demonstrated and explained in detail, for the first time, the amenability of the automated ambr15 cell culture microbioreactor system for the development of scalable adherent human mesenchymal multipotent stromal/stem cell (hMSC) microcarrier culture processes. This was achieved by first improving suspension and mixing of the microcarriers and then improving cell attachment thereby reducing the initial growth lag phase. The latter was achieved by using only 50% of the final working volume of medium for the first 24 h and using an intermittent agitation strategy. These changes resulted in >150% increase in viable cell density after 24 h compared to the original process (no agitation for 24 h and 100% working volume). Using the same methodology as in the ambr15, similar improvements were obtained with larger scale spinner flask studies. Finally, this improved bioprocess methodology based on a serum-based medium was applied to a serum-free process in the ambr15, resulting in >250% increase in yield compared to the serum-based process. At both scales, the agitation used during culture was the minimum required for microcarrier suspension, N

Indexed as

BioreactorsBatch Cell Culture TechniquesCell Culture TechniquesCell ProliferationCells, CulturedCulture Media, Serum-FreeEquipment DesignEquipment Failure AnalysisHumansMesenchymal Stem CellsMicrofluidicsMiniaturizationPilot ProjectsRoboticsCulture Media, Serum-Freebioprocessingcell therapyhuman mesenchymal multipotent stromal cellmicrobioreactormicrocarrierscale down

Identifiers

PMID28627713
PMCPMC5615370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.